[Medical treatment of peripheral occlusive arteriopathies. Possibilities, principles and basis].
D000721:Ancrod / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D012103:Batroxobin / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D008901:Mineralocorticoids / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000925:Anticoagulants; D003911:Dextrans; D004071:Digitalis Glycosides; D005343:Fibrinolytic Agents; D008901:Mineralocorticoids; D014665:Vasodilator Agents; D000721:Ancrod; D012103:Batroxobin
Il trattamento medico delle arteriopatie occlusive periferiche. Possibilità, principi e basi.